首页> 外文期刊>Scandinavian journal of clinical and laboratory investigation. >Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China
【24h】

Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China

机译:中国中部地区苯丙酮尿中苯丙氨酸羟化酶基因的突变谱

获取原文
获取原文并翻译 | 示例
           

摘要

Phenylketonuria (PKU, OMIM 261600) caused by phenylalanine hydroxylase (PAH) deficiency is an autosomal recessive disease that is characterized by abnormalities of phenylalanine metabolism. In this study, a total of 77 patients, originating from the central region of China and who were diagnosed with PAH deficiency at the third affiliated hospital of Zhengzhou University, were enrolled in this study. The 13 exons and 12 flanking introns of the PAH gene were analyzed by Sanger sequencing and next generation sequencing. The sequencing data were aligned to the hg19, PAHvdb and HGMD databases to characterize the genotypes of PKU patients, and genotype-phenotype correlations and BH4 responsiveness predictions were performed using BIOPKUdb. In total, 149 alleles were characterized among the 154 PKU alleles. These mutations were located in exons 2-13, and intron 12 of the PAH gene, with a relative frequency of 5%, for EX6-96AG, p.R241C, p.R243Q, p.V399V and p.R53H. Additionally, a novel variant, p.D84G, was identified. The genotype correlated with clinical symptoms in 33.3-100% of the cases, depending on the disease severity, and BH4 responsiveness predictions show that only five patients with MHP-PKU and one patient with Mild-PKU were predicted to be BH4 responsive. In conclusion, we have characterized the mutational spectrum of PAH in the central region of China and have identified a novel mutation. The hotspot mutation information might be useful for screening, diagnosis and treatment of PKU.
机译:苯丙氨酸羟化酶(PKU,OMIM 261600)由苯丙氨酸羟化酶(PAH)缺乏是一种常染色体隐性疾病,其特征在于苯丙氨酸代谢的异常。在这项研究中,共有77名患者源自中国中部地区,曾在郑州大学第三附属医院诊断出患有PAH缺乏的患者,并于此研究。通过Sanger测序和下一代测序分析PAH基因的13个外显子和12个侧翼内含子。测序数据与HG19,PAHVDB和HGMD数据库对齐,以表征PKU患者的基因型,使用BIOPKUDB进行基因型 - 表型相关性和BH4反应性预测。共有149个等位基因的特征在154个PKU等位基因中。这些突变位于外显子2-13和PAH基因的内含子12,相对频率为5%,对于ex6-96a& g,p.r241c,p.r243q,p.v399v和p.r53h。另外,鉴定了一种新型变体p.d84g。基因型与临床症状相关的33.3-100%,这取决于疾病严重程度,BH4反应性预测表明,只预计只有五名MHP-PKU和一个患有轻度PKU的患者响应于BH4。总之,我们在中国中部地区的PAH的突击谱表现​​了鉴定了一种新的突变。热点突变信息可能对PKU的筛选,诊断和治疗有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号